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ABSTRACT
Management of Takayasu’s arteritis of the left main coronary artery (LMCA) is difficult because of the possibility of restenosis. 
Clinically significant stenotic lesions must be considered anatomical correlation. Many studies have reported that the manage-
ment of stenotic lesions of the LMCA with endoluminal stenting and balloon angioplasty and de-novo stenting is safe and ef-
fective for patients with Takayasu’s arteritis. We report the case of a patient with Takayasu’s arteritis of the LMCA. The patient 
had undergone two consecutive percutaneous coronary interventions because of recurrent restenosis of in-stent lesions, and 
eventually underwent coronary artery bypass graft (CABG) surgery for myocardial infarction in the same lesion. We suggest-
ed treatment with CABG because the pathophysiology of Takayasu’s arteritis is different from that of atherosclerotic stenosis. 
(Korean Circ J 2011;41:34-37)
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Introduction
Takayasu’s arteritis is an idiopathic vasculitis of the large ves-
sel involving the aorta and the subclavian and innominate ar-
teritis.
1-3) Takayasu’s arteritis is one of the most common causes 
of hypertension in adolescents, and differences in blood pres-
sures between both arms is a common sign of Takayasu’s ar-
teritis in adults. Clinical deterioration caused by severe fixed 
stenosis is a challenging issue because of restenosis of in-stent 
lesions.
4)5) A previous study has suggested that endoluminal 
stenting may be an alternative treatment to coronary artery by-
pass graft (CABG) surgery for patients with coronary artery 
stenosis due to active Takayasu’s arteritis.
6) Some studies have 
reported that Takayasu’s arteritis with left main coronary ar-
tery (LMCA) stenosis is successfully treated with the use of 
a sirolimus-eluting stent and a paclitaxel-eluting stent after re-
peated in-stent restenosis following bare metal stenting.
4)7-9) 
However, we report here the case of a 54-year-old woman with 
recurrent restenosis of an in-stent lesion followed by myocar-
dial infarction, who eventually underwent CABG. 
Case
A 54-year-old woman presented with recently developed dy-
spnea on exertion. She was previously healthy and had no symp-
toms except for exertional dyspnea. However, a discrepancy 
in blood pressure measurements between the right and left arms 
was noted during a routine examination (right arm: 70/40 mmHg; 
left arm: 130/80 mmHg). Bruit was audible in the right subcla-
vian area, and right radial pulsation was not palpable. On ad-
mission, we performed peripheral angiography and coro-
nary angiography. The peripheral angiography revealed total 
occlusion of the right subclavian artery (Fig. 1). The coronary 
angiography showed a 60% focal stenosis in the ostium of the 
LMCA (Fig. 2A).
The LMCA was engaged with a 6 Fr guiding catheter via the 
femoral artery, and a 0.014 inch Hi-torque Whisper MS
TM gu-
idewire (Guidant, Santa Clara, CA, USA) was able to cross the 
lesion without difficulty. We predilated the lesion with an ART Hyo Keun Lee, et al.   35
2.5×20 mm ART
TM balloon (AMG, Raesfeld-Erle, Germany) 
up to 8 atm and then deployed a PICO
TM 4.0×10 mm stent 
(AMG) at a maximum of 20 atm. The angiographic result was 
good (Fig. 2B). The patient was discharged the next day and 
took aspirin and clopidogrel. Anti-inflammatory agents were 
not prescribed to the patient because the erythrocyte sedimen-
tation rate and the C-reactive protein concentration were wi-
thin normal ranges at the time of discharge. Although the pa-
tient had been asymptomatic over the next 3 months, a follow-
up coronary angiography was performed at 3 months because 
many cases of coronary artery restenosis in Takayasu’s arte-
ritis occur without detectable cardiac symptoms. An intravas-
cular ultrasound was also performed at this time, which showed 
a 75% segmental stenosis in the proximal portion of the in-st-
ent lesion area; however, the other sites had normal coronary 
vascular features (Fig. 3A). We performed a percutaneous co-
ronary intervention (PCI) at the site of the in-stent resteno-
sis lesion and used a TAXUS
TM 3.5×12 mm stent (Boston Sci-
entific, Boston, MA, USA) at a maximum of 22 atm; a good an-
giographic result was obtained (Fig. 3B). The patient took medi-
cations, including aspirin, clopidogrel, and cilostazol. Three 
months later, she experienced resting chest pain and dyspnea. 
A chest X-ray showed pulmonary edema in both lower lung 
fields. An electrocardiogram showed an ST depression and a 
T wave inversion on precordial leads, and the concentration of 
the cardiac enzyme creatine kinase was elevated (38.11 ng/mL). 
The patient became hypotensive (blood pressure, right arm: 
75/50 mmHg). Echocardiography indicated global hypoki-
nesia, with a 40% ejection fraction. A follow-up coronary an-
giography revealed tight stenosis greater than 90% in the dis-
tal portion of the in-stent site (Fig. 4). On the basis of these find-
ings, we performed an emergency CABG, which was success-
ful. One year later, the patient underwent coronary angiogra-
phy. No new stenotic lesions or graft stenosis was observed. 
A   B  
Fig. 1. Angiography of the right subclavian artery show total occlusion (black arrow) near the origin and marked dilation of the collateral artery 
(white arrows) originating from the thyrocervical trunk in the early phase (A) and a reconstituted axillary artery (black arrow) via dilated collat-
erals (white arrow) in later phase (B).
Fig. 2. Angiography of the left coronary angiography show focal stenosis in the ostium of left main coronary artery (A) and a paclitaxel-eluting 
stent deployed in the ostium of the left main coronary artery (B).
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Discussion
Takayasu’s arteritis is an idiopathic vasculitis of the large 
vessel that affects the aorta and its major branches.
1-3)10) The co-
ronary artery is a rare site of Takayasu’s arteritis, reportedly oc-
curring in only 6-19% of cases; the most common site of cor-
onary stenosis is the ostium of the LMCA.
5)11)12) 
Clinical manifestations of Takayasu’s arteritis of the coro-
nary artery include angina pectoris and myocardial infarc-
tion.
13-15) The recommended treatment of Takayasu’s arteritis 
with LMCA stenosis with is percutaneous angioplasty or sur-
gery. For poor surgical candidates or patients who prefer a 
nonsurgical treatment, PCI may be a more beneficial revascu-
larization strategy than CABG.
4)11)16) Some investigators have 
reported that drug-eluting stents are more efficacious than are 
bare-metal stents.
5)7-9) For example, many studies recently re-
ported a lower incidence of restenosis in the coronary artery 
with the use of drug-eluting stents than with bare-metal stents. 
Although various strategies have been used to prevent in-
stent restenosis, restenosis is still a problem. In our patient, re-
stenosis was observed in the in-stent lesion after consecutive 
coronary angioplasties. 
We deployed a drug-eluting stent in the LMCA. However, 
in-stent restenosis occurred, and the patient was admitted to 
the hospital because of myocardial infarction. Matsubara et 
al.
11) classified coronary lesions on the basis of pathological 
features and reported stenosis or occlusion of the ostia. The 
extension of the inflammatory process of the intimal prolifer-
ation and contraction of the fibrotic media and adventitia cau-
se luminal narrowing. Thus, drug-eluting stents may provide 
effective results through an antiproliferative effect against 
vascular smooth muscle cells. However, because of differenc-
es in the etiologies and in the inflammatory/immune-mediat-
ed processes of atherosclerosis and Takayasu’s arteritis, the use 
of coronary stenting-which is effective for the treatment of ath-
erosclerotic stenosis lesions-may not be safe or effective for the 
treatment of Takayasu’s arteritis. In a previous study, favorable 
results of percutaneous stent implantation for LMCA stenosis 
in Takayasu’s arteritis were reported.
5)7-9)
However, previous studies showing favorable results had li-
mited success in Takayasu’s arteritis with good patency be-
cause of short and intermediate follow-up times after percu-
taneous stent implantation for LMCA stenosis.
5-7)17)18) Son et 
al.
6) refer to stent insertion as a therapy used to postpone CA-
BG. The lesions most commonly affected by Takayasu’s arte-
ritis are the ostial or proximal coronary segments, which pose 
Fig. 3. A follow-up coronary angiography shows 75% segmental stenosis in the proximal portion of the in-stent lesion area (A) and another pa-
clitaxel-eluting stent (TAXUS
TM) deployed in the in-stent lesion (B).
A   B  
Fig. 4. Coronary angiography shows tight insent restenosis after sec-
ond intervention in the ostium of the left main coronary artery.Hyo Keun Lee, et al.   37
anatomic challenges for the performance of PCI. Surgical tr-
eatments are often more suitable for patients with Takayasu’s 
arteritis because of the pathophysiologic characteristics of this 
disease. Sakai et al.
8) reported that both short-term and long-
term follow-up are required to evaluate the effects of drug-elut-
ing stents on Takayasu’s arteritis. Son et al.
6) suggest that endo-
luminal stenting and rotational atherectomy may be useful tr-
eatments for postponing CABG in patients with coronary ar-
tery stenosis due to active Takayasu’s arteritis. 
For our patient, we recommended CABG for the treatment 
of Takayasu’s arteritis involving the LMCA because the patho-
physiology of this condition is different from that of athero-
sclerotic stenosis.
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